Below is a list of current Australian researchers recruiting for participants. Please direct any queries about specific studies to the contact of the study.
You can search for a study by state or select All States for those studies which are national.
If you have any questions regarding content on this page or want to modify your study once submitted please email research@dementia.org.au
The SAMe Study is a research project investigating a potential treatment for Alzheimer's disease, called S-Adenosyl Methionine, or more commonly known as “SAMe”. It is thought that Alzheimer's disease may be caused by the toxic build-up of proteins in the brain such as tau and amyloid-beta. This study is looking at whether taking SAMe once a day will reduce tau protein levels.
You or…
The aim of this study is to evaluate the effect of JNJ-63733657, which is a monoclonal anti-tau antibody to prevent collection of tau in the brain by clearing it from the brain. The study will investigate whether JNJ-63733657 can slow cognitive decline in participants with Early Alzheimer’s disease with evidence of elevated brain tau (T+) and assess its safety and tolerability.
Who can…
This is a Phase 3 study to test whether treatment with BAN2401 prevents cognitive decline and reduces brain amyloid accumulation, which is considered as one of the causes of Alzheimer’s disease. The changes in the amount of amyloid and tau in the brain will be monitored to determine the efficacy of the investigational medication.
Who can be involved?
- Male or female, aged…
Currently there are no approved treatments for fronto-temporal dementia. The main purpose of this research project is to look at whether the trial drug, sodium selenate decreases the rate of brain shrinkage in patients with fronto-temporal dementia. The research project will also look into the effect of sodium selenate on brain function and markers of disease measured on brain scans, in blood…
This project seeks to identify whether eye and brain tests can serve as early diagnostic markers for Alzheimer’s disease and dementia. We will evaluate the potential correlation of retinal, structural and functional changes within the eye to brain changes including cognitive decline and progression over a period of five years.
Participants must meet the following criteria:
- …
While it is well known that people with Parkinson’s disease (PD) experience problems with their movement, it is lesser known that around 80% of people with PD develop dementia. Research conducted at Johns Hopkins University in the U.S.A. has found that low doses of the anti-epileptic drug levetiracetam can reduce memory problems in people prone to Alzheimer’s disease.
The aim of this…
Hearing loss is a modifiable risk factor for dementia, yet approximately 83% of people or more with hearing loss do not use hearing devices.
This research project aims to investigate the effect of hearing aid and cochlear implant use on cognition in older adults, controlling for other dementia risk factors. These effects have not yet been examined in a longitudinal study that…
This research study is exploring the relationship between gait (walking pattern) and thinking. We are interested in how walking patterns, such as walking with small shuffling steps or unsteadiness when turning and avoiding obstacles, are related to problem solving and thinking. We plan to use this information to develop interventions to help people to walk safely, and reduce their risk of…
StepUp for Dementia Research is an online, postal and telephone service that connects people interested in participating in dementia research with researchers conducting studies into dementia prevention, diagnosis, treatment, care and cure. Anyone in Australia aged 18 and over, with or without dementia, can sign up for StepUp for Dementia Research. Once registered, volunteers will be matched…
Dementia with Lewy bodies (DLB) is a relatively common form of dementia in older age. People with DLB often have similar symptoms to people with Alzheimer’s disease and Parkinson’s disease. Lewy bodies are tiny deposits of alpha-synuclein (a protein) in the nerve cells of the brain. It is not known exactly what causes the abnormal build-up of these Lewy bodies in the brain. In order to find an…